SG Americas Securities
PRME icon

SG Americas Securities’s Prime Medicine PRME Stock Holding History

SG Americas Securities’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
+58,922
New +$196K ﹤0.01% 2767
2026
Q1 		– Sell
-30,954
Closed -$107K – 3596
2025
Q4 		$107K Buy
+30,954
New +$138K ﹤0.01% 3220
2025
Q3 		– Sell
-27,919
Closed -$69K – 3526
2025
Q2 		$69K Sell
27,919
-23,537
-46% -$36.3K ﹤0.01% 2714
2025
Q1 		$102K Sell
51,456
-8,773
-15% -$22.4K ﹤0.01% 3037
2024
Q4 		$176K Buy
60,229
+13,247
+28% +$46.5K ﹤0.01% 2269
2024
Q3 		$182K Buy
+46,982
New +$218K ﹤0.01% 2580
2024
Q1 		– Sell
-10,128
Closed -$90K – 3345
2023
Q4 		$90K Buy
+10,128
New +$78K ﹤0.01% 2803

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SG Americas Securities's PRME Position: Q2 2026 in Review

SG Americas Securities opened a new position in Prime Medicine (PRME) in Q2 2026: 58,922 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #2767 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in PRME as recently as Q4 2025.

SG Americas Securities first reported a position in PRME in Q4 2023 and has held it in 7 quarters since. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • SG Americas Securities held 58,922 shares of Prime Medicine worth $217K as of Q2 2026.
  • Prime Medicine was a new SG Americas Securities position in Q2 2026.
  • Prime Medicine made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2767 holding.
  • SG Americas Securities first reported a position in Prime Medicine in Q4 2023 and has held it in 7 quarters since.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.